Skip to content
  • Our Company
    • Our Purpose
    • Our Leadership
    • Our Locations
  • Our Focus
    • The Problem
    • Uterine Fibroids
    • Endometriosis
    • Prostate Cancer
    • Infertility
  • Our Science
    • Pipeline
    • Relugolix Combination Tablet
    • MVT-602
  • Our Medicines
  • Our Advocacy
    • Forward Together
  • Join The Team
    • Our Culture
    • Our Benefits
    • Open Positions
  • For Media
    • Press Releases
    • Events
    • Presentations
    • Corporate Governance
    • Expanded Access
  • Contact Us
  • Twitter
  • LinkedIn
  • Instagram
  • Pipeline
  • Relugolix Combination Tablet
  • MVT-602
  • Board of Directors
  • Documents & Charters
  • Committee Composition
  • Expanded Access
  • Visibility: Public

    Menstrual Mysteries—Mothers and Daughters Talk About Periods

    A video series to open up the conversation about menstruation.

    3 Ways to Improve Endometriosis Diagnosis

    Getting a diagnosis for endometriosis can take years. Why does this happen?

    Men with Prostate Cancer Find Support

    A video series on how men with prostate cancer find strength in community.

    Overcoming Stigma with Care and Community

    Thomasine’s journey through uterine fibroids started with pain but led to empowerment.

    Our Company
    • Our Purpose
    • Our Leadership
    • Our Locations
    Our Focus
    • The Problem
    • Uterine Fibroids
    • Endometriosis
    • Prostate Cancer
    • Infertility
    Our Science
    • Pipeline
    • Relugolix Combination Tablet
    • MVT-602
    Our Medicines
    Our Advocacy
    • Forward Together
    Join the Team
    • Our Culture
    • Our Benefits
    • Open Positions
    For Media
    • Press Releases
    • Events
    • Presentations
    • Corporate Governance
    • Expanded Access
    Contact Us

    © 2023 Myovant Sciences GmbH. All rights reserved.

    • Terms of Use
    • Privacy Policy
    • Cookie Policy
    • SMS Terms & Conditions
    • Compliance & Prescriber Information
    OUR COMPANY
    Our Purpose
    Our Leadership
    Our Locations
    OUR FOCUS
    The Problem
    Uterine Fibroids
    Endometriosis
    Prostate Cancer
    Infertility
    OUR SCIENCE
    Pipeline
    Relugolix Combination Tablet
    MVT-602
    OUR MEDICINES
    OUR ADVOCACY
    Forward Together
    JOIN THE TEAM
    Our Culture
    Our Benefits
    Open Positions
    INVESTORS & MEDIA
    Company Overview
    News & Events
    Stock Information
    Financials & Filings
    Corporate Governance
    Email Alerts
    CONTACT US
    TWITTER
    LINKEDIN
    Instagram
    • OUR COMPANY
      • Our Purpose
      • Our Leadership
      • Our Locations
    • OUR FOCUS
      • The Problem
      • Uterine Fibroids
      • Endometriosis
      • Prostate Cancer
      • Infertility
    • OUR SCIENCE
      • Pipeline
      • Relugolix Combination Tablet
      • MVT-602
    • OUR MEDICINES
    • OUR ADVOCACY
      • Forward Together
    • JOIN THE TEAM
      • Our Culture
      • Our Benefits
      • Open Positions
    • INVESTORS & MEDIA
      • Company Overview
      • News & Events
      • Stock Information
      • Financials & Filings
      • Corporate Governance
      • Email Alerts
    • CONTACT US
    • TWITTER
    • LINKEDIN
    • Instagram